Lastest from Businesswire
IBRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ImmunityBio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)---- $IBRX #IBRX--The case alleges ImmunityBio materially overstated Anktiva’s capabilities.

